APYX MEDICAL CORPORATION TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES IN NOVEMBER
CLEARWATER, FL — NOVEMBER 07, 2023 – Apyx® Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium plasma and radiofrequency technology marketed and sold as Renuvion®, announced today that management will participate in the following upcoming investor conferences:
The Stephens Annual Investment Conference at the Nashville Grand Hyatt in Nashville, TN
- Management will participate in a fireside chat on Tuesday, November 14 at 12:00 p.m. Eastern Time.
The Craig-Hallum 14th Annual Alpha Select Conference at the Sheraton NY Times Square Hotel in New York, NY
- Management will participate in 1×1 meetings on Thursday, November 16. There will be no formal presentation.
The Piper Sandler 35th Annual Healthcare Conference at the Lotte New York Palace in New York, NY
- Management will participate in a fireside chat on Wednesday, November 29 at 4:00 p.m. Eastern Time.
Audio webcasts of the fireside chat will be provided under the ‘Company Events’ section of the Apyx Medical Corporation investor relations website at https://apyxmedical.com/investor_relations/. The webcasts will be achieved and available for replay following the conferences.
About Apyx Medical Corporation
Apyx Medical Corporation is an advanced energy technology company with a passion for elevating people’s lives through innovative products, including its Helium Plasma Technology products marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma® in the hospital surgical market. Renuvion and J-Plasma offer surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The Company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers. For further information about the Company and its products, please refer to the Apyx Medical Corporation website at www.ApyxMedical.com.
Investor Relations Contact
ICR Westwicke on behalf of Apyx Medical Corporation
Mike Piccinino, CFA